A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function
Clinical trial NCT03282513 · COMPLETED
Trial details
- NCT number
- NCT03282513
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2018-03-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.